Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Jul 31, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,94015 flagged findings
Reported transactions (Form 4)43since Apr 30, 2025 · and 15 other holdings
Corporate events (8-K)30since Feb 23, 2021
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
The 25 most recent filings (of 1,940)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 9, 268-K ↗Current report · A senior executive left or was appointed
- Sep 17, 26Form 3 ↗Insider transaction
- Sep 16, 268-K ↗Current report · A senior executive left or was appointed
- Sep 8, 26Form 4 ↗Insider transaction
- Sep 4, 26SCHEDULE 13G ↗Passive stake · BlackRock Portfolio Management LLC · 10.4% · event on Aug 31, 26
- Aug 17, 26Form 4 ↗Insider transaction
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · amendment
- Aug 14, 26SCHEDULE 13G ↗Passive stake · Vestal Point Capital, LP · 6.1% · event on Jun 30, 26
- Aug 7, 26SCHEDULE 13G ↗Passive stake · STATE STREET CORPORATION · 5.3% · event on Jun 30, 26
- Jul 31, 2610-Q ↗Quarterly report
- Jul 30, 268-K ↗Current report · Results
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 268-K ↗Current report · A senior executive left or was appointed
- Jun 8, 26Form 144 ↗Notice of proposed sale
1,940 filings on record, the oldest from Nov 8, 96.
Listing the 25 most recent filings of the 1,940 on record.
14257
7 senior executive changes2025 – 2026show all 7hide
- Oct 9, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Sep 16, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 23, 26A senior executive left or was appointed8-K 5.02 ↗
- Jun 4, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 7, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Oct 3, 25A senior executive left or was appointed8-K 5.02 ↗
- Aug 18, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jul 31, 25Took on a new financial obligation+3 more in the same filing8-K 2.03 ↗
4 senior executive changes2023 – 2025show all 4hide
- Jun 5, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Feb 24, 25A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Dec 10, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Dec 21, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Nov 13, 23Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Nov 1, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Oct 31, 23Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Oct 5, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Aug 3, 23Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
- Jul 6, 23Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jun 2, 23A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Jul 27, 22Took on a new financial obligation+2 more in the same filing8-K 2.03 ↗
5 senior executive changes2021 – 2022show all 5hide
- Jun 30, 22A senior executive left or was appointed8-K 5.02 ↗
- Jun 2, 22A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Feb 9, 22A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jan 4, 22A senior executive left or was appointed8-K 5.02 ↗
- Dec 14, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
1 older filings not shown · The record reaches back to Nov 12, 04.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Mar 25, 05Listing notice (8-K 3.01)8-K 3.01 ↗
The full record holds 1 stress filing.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- BlackRock Portfolio Management LLC10.4%Aug 31, 26SCHEDULE 13G ↗
- BlackRock, Inc.8.5%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing
- The Vanguard Group8.5%Sep 30, 25SCHEDULE 13G/A ↗
- Millennium Management LLC7.2%Dec 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- Vestal Point Capital, LP6.1%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 3 more holdershide
- STATE STREET CORPORATION5.3%Jun 30, 26SCHEDULE 13G ↗2 earlier filings
- GLENVIEW CAPITAL MANAGEMENT, LLC5.3%Jan 6, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Barclays PLC4.2%Sep 30, 25SCHEDULE 13G/A ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Stock compensation, tax and giftsshow the 38 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 21, 26Tax$10KBenjamin Richard WheelerChief Financial Officer↗
- Sep 16, 26Compensationamount n/aVishal SikriEVP, Commercial↗
- Sep 3, 26Tax$14KJennifer Lynne FoxChief Legal Officer↗
- Aug 16, 26Tax$27KBenjamin Richard WheelerChief Financial Officer↗
- Jun 11, 26Compensation$14KSamraat S. RahaPresident and CEO↗
- Jun 11, 26Compensation$20KBrian J DonnellyChief Commerical Officer↗
- Jun 4, 26Compensationamount n/aPaul Bisaro↗
- Jun 4, 26Compensationamount n/aHeinrich Dreismann↗
- Jun 4, 26Compensationamount n/aS. Louise Phanstiel↗
- Jun 4, 26Compensationamount n/aDaniel Skovronsky↗
- Jun 4, 26Compensationamount n/aColleen F Reitan↗
- Jun 4, 26Compensationamount n/aLee Nisley Newcomer↗
- Jun 4, 26Compensationamount n/aRashmi Kumar↗
- Jun 4, 26Compensationamount n/aMark Steven Davis↗
- Jun 1, 26Compensationamount n/aRaj JampaChief Technology Officer↗
- May 1, 26Tax$269KBrian J DonnellyChief Commerical Officer↗
- Apr 14, 26Tax$5KMark VerrattiChief Operating Officer↗
- Apr 14, 26Tax$5KDale MuzzeyChief Scientific Officer↗
- Mar 22, 26Tax$9KMark VerrattiChief Operating Officer↗
- Mar 22, 26Tax$9KDale MuzzeyChief Scientific Officer↗
- Mar 22, 26Tax$3KBenjamin Richard WheelerChief Financial Officer↗
- Mar 15, 26Tax$26KMark VerrattiChief Operating Officer↗
- Mar 15, 26Tax$42KMark VerrattiChief Operating Officer↗
- Mar 15, 26Tax$16KKevin Richard HaasChief Technology Officer↗
- Mar 15, 26Tax$39KKevin Richard HaasChief Technology Officer↗
- Mar 15, 26Tax$22KDale MuzzeyChief Scientific Officer↗
- Mar 15, 26Tax$56KDale MuzzeyChief Scientific Officer↗
- Mar 15, 26Tax$4KBenjamin Richard WheelerChief Financial Officer↗
- Mar 15, 26Tax$10KBenjamin Richard WheelerChief Financial Officer↗
- Mar 14, 26Tax$27KShereen SolaimanChief People Officer↗
- Mar 14, 26Tax$25KMark VerrattiChief Operating Officer↗
- Mar 14, 26Tax$50KSamraat S. RahaPresident and CEO↗
- Mar 14, 26Tax$19KKevin Richard HaasChief Technology Officer↗
- Mar 14, 26Tax$39KDale MuzzeyChief Scientific Officer↗
- Mar 14, 26Tax$5KBenjamin Richard WheelerChief Financial Officer↗
- Mar 13, 26Tax$41KShereen SolaimanChief People Officer↗
- Mar 13, 26Tax$43KMark VerrattiChief Operating Officer↗
- Mar 13, 26Tax$169KSamraat S. RahaPresident and CEO↗
The full record holds 294 transactions and goes back to Jan 1, 23.
Its sector and its market
Myriad Genetics Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Myriad Genetics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Myriad Genetics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 1,940 documents on file, from Nov 8, 1996 to Oct 9, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.